Desiderio, Antonella
Longo, Michele
Parrillo, Luca
Campitelli, Michele
Cacace, Giuseppe
de Simone, Sonia
Spinelli, Rosa
Zatterale, Federica
Cabaro, Serena
Dolce, Pasquale
Formisano, Pietro
Milone, Marco
Miele, Claudia
Beguinot, Francesco http://orcid.org/0000-0002-4946-7803
Raciti, Gregory A.
Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2015, PRIN 2017)
Regione Campania (POR FESR 2014-2020 – Obiettivo specifico 1.2. - Manifestazione di Interesse per la Realizzazione di Technology Platform nell’ambito della Lotta alle Patologie Oncologiche” - COEPICA, POR FESR 2014-2020 – Obiettivo specifico 1.2. - Manifestazione di Interesse per la Realizzazione di Technology Platform nell’ambito della Lotta alle Patologie Oncologiche” - RARE PLAT NET, POR FESR 2014-2020 – Obiettivo specifico 1.2. - Manifestazione di Interesse per la Realizzazione di Technology Platform nell’ambito della Lotta alle Patologie Oncologiche” - SATIN)
Italian Diabete Ricerca Foundation and Eli Lilly Italy (2018-2020)
European Foundation for the Study of Diabetes (EFSD)/Boehringer Ingelheim (2018-2020)
Article History
Received: 28 May 2019
Accepted: 21 October 2019
First Online: 4 December 2019
Ethics approval and consent to participate
: The study adhered to the Code of Ethics of the World Medical Association (Declaration of Helsinki) and has been reviewed and approved by the Ethic Committee of the Federico II University of Naples (Ethics Approval Number: No. 254/17). Informed consent was obtained individually from all of the subjects enrolled in the study.
: Not applicable.
: The authors declare that they have no competing interests.